Approvals for Clinical Trial Applications
Approved Clinical Trial Applications can be found in The European Union Clinical Trials Register, https://www.clinicaltrialsregister.eu/2019
The IMA has approved five clinical trials in the year 2019
On the 10th of October 2019 IMA approved a multinational phase III trial for oncology.
On the 26th of June 2019 IMA approved a multinational phase II trial for atopic dermatitis.
On the 6th of March 2019 IMA approved a
clinical trial for a genetic disease. This is a phase IIa trial only performed in
Iceland.
On the 4th of March 2019 IMA approved a multinational phase II trial for atopic dermatitis.
On the 4th of March 2019 IMA approved a multinational phase IIIb trial for atopic dermatitis.
2018
The IMA has approved three clinical trials in the year 2018
On 12 December 2018 IMA approved a multinational phase II trial in oncology.
On the 29th of November 2018 IMA approved a trial in oncology. This is a phase II trial only performed in Iceland.
On the 29th of May 2018 IMA approved a multinational phase II trial for atopic dermatitis.
2017
The IMA has approved five clinical trials in the year 2017
On the 22nd of September IMA approved a multinational phase II/III trial for dementia.
On the 11th of April 2017 IMA approved a trial in cardiology. This is a phase IV trial only performed in Iceland.
On the 11th of April 2017 IMA approved a multinational phase IIIb trial in rheumatology.
On the 27th of March 2017 IMA approved a multinational phase IIIb trial in cardiology.
On the 12th of January 2017 IMA approved a multinational phase III trial in dermatology.
2016
The IMA has approved nine clinical trials in the year 2016
On 30 December 2016 IMA approved a multinational phase III trial in gastroenterology.
On 30 December 2016 IMA approved a multinational phase III trial in gastroenterology.
On 21 December 2016 IMA approved a multinational phase IIb/III trial in gastroenterology.
On 21 December 2016 IMA approved a multinational phase III trial in gastroenterology.
On 21 September 2016 IMA approved a multinational phase IIIb trial in dermatology.
On 8 June 2016 IMA approved a multinational phase IV trial in oncology.
On 4 May 2016 IMA approved a multinational phase III trial in dermatology.
On 28 April 2016 IMA approved a multinational phase II/III trial in gastroenterology.
On 7 April 2016 IMA approved a multinational phase II trial in gastroenterology.
2015
The IMA has approved seven clinical trials in the year 2015
On 29 December 2015 IMA approved a multinational phase III trial in respiratory disease.
On 30 November 2015 IMA approved a clinical trial in dermatology. This is a phase IV trial only performed in Iceland.
On 2 July 2015 IMA approved a multinational phase II trial in immunology.
On 29 June 2015 IMA approved a trial in gastroenterology. This is a phase IV trial only performed in Iceland.
On 17 March 2015 IMA approved a multinational phase III trial in cardiology.
On 10 February 2015 IMA approved multinational phase III trial in cardiology.
On 23 January 2015 IMA approved a multinaltional phase II trial in dermotology.